Header Logo

Connection

JAN SUNDE to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications JAN SUNDE has written about Dose-Response Relationship, Drug.
JAN SUNDE
Connection Strength
0.012
Dose-Response Relationship, Drug
  1. A phase I trial of oxaliplatin and topotecan in recurrent ovarian carcinoma. Gynecol Oncol. 2007 Feb; 104(2):422-7.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.